Your session is about to expire
← Back to Search
Online Treatment Platform for Traumatic Stress Disorders
Study Summary
This trial seeks to explore if an online self-managed treatment platform can be effective for reducing psychological symptoms in sexual assault survivors, offering potential to fill a service gap for this population.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I can read and speak French.You have symptoms of stress, depression, and/or trouble sleeping.I identify as a woman, at least partially.I can read and speak French.I am 18 years old or older.I am currently seeing improvements from my mental health treatment.I identify as a woman, at least partially.I can read and speak French.I have a history of bipolar or psychotic disorder.I am 18 years old or older.I have symptoms of PTSD, mild depression, or trouble sleeping.You have had a serious allergic reaction after the age of 12.I identify as a woman, at least partially.
- Group 1: Self-Managed Online Treatment
- Group 2: Therapist-Assisted Online Treatment
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are individuals still being sought for participation in this experiment?
"Correct. Clinicaltrials.gov attests that this medical trial, posted on August 1st 2022 and last modified March 31 2023, is currently accepting participants. A total of 204 patients can be recruited from a single centre."
How many participants are currently enrolled in this research study?
"Affirmative. Clinicaltrials.gov indicates that this clinical trial began on August 1st 2022 and was last revised March 31st 2023 with the aim of recruiting 204 participants from one site."
What are the objectives of this investigation?
"This clinical trial aims to assess its efficacy in treating depression over a 3 month period, with secondary measures encompassing nightmares severity (as recorded by the NDQ), anxiety symptoms as measured via GAD-7 and participants' perceptions of their violence experience through the Rape Attribution Questionnaire."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger